Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment

Background and purpose Subacute and chronic peripheral neuropathies (PNP) have been reported in Parkinson's disease (PD) patients treated with levodopa/carbidopa intestinal gel infusion (LCIG), although several aspects of their incidence and pathogenesis still remain to be clarified. This study...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology 2016-03, Vol.23 (3), p.501-509
Hauptverfasser:	Merola, A., Romagnolo, A., Zibetti, M., Bernardini, A., Cocito, D., Lopiano, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse events Aged Antiparkinson Agents - administration & dosage Antiparkinson Agents - adverse effects Carbidopa - administration & dosage Carbidopa - adverse effects Drug Combinations EMG Female Gels Humans Infusions, Parenteral Levodopa - administration & dosage Levodopa - adverse effects Male Middle Aged Parkinson Disease - drug therapy Parkinson's disease Peripheral Nervous System Diseases - chemically induced Peripheral Nervous System Diseases - diagnosis polyneuropathy Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!